Isolation of macrophage-like cell mutants resistant to the cytotoxic effect of oxidized low density lipoprotein

Journal of Lipid Research

Volumn 39, Issue 3, 1998, Pages 482-494

  Hakamata, Hideki ^a   Miyazaki, Akira ^a   Sakai, Masakazu ^a   Matsuda, Hirofumi ^a   Suzuki, Hiroshi ^b   Kodama, Tatsuhiko ^c   Horiuchi, Seikoh ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atherosclerosis; Cytotoxicity; Macrophage; Macrophage scavenger receptors; Oxidized low density lipoprotein; Somatic cell mutant

Indexed keywords

COMPLEMENTARY DNA; IODINE 125; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; SCAVENGER RECEPTOR;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL MUTANT; CONTROLLED STUDY; CYTOTOXICITY; ISOTOPE LABELING; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC CELL GENETICS;

ANIMALS; BLOTTING, NORTHERN; CELL DEATH; CELL LINE; DRUG RESISTANCE; ENDOCYTOSIS; KETOCHOLESTEROLS; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES; MACROPHAGES; MACROPHAGES, PERITONEAL; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MUTATION; PEROXIDES; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS B; TERT-BUTYLHYDROPEROXIDE;

EID: 0031918870     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for 1990s. Nature. 362: 801-809.
2. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
3. Krieger, M., and J. Herz. 1994. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63: 601-637.
4. Acton, S. L., P. E. Scherer, H. F. Lodish, and M. Krieger. 1994. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269: 21003-21009.
5. Pearson, A., A. Lux, and M. Krieger. 1995. Expression cloning of dSR-CI, a class C macrophage-specific scavenger receptor from Drosophila melanogaster. Proc. Natl. Acad. Sci. USA. 92: 4056-4060.
6. Kodama, T., M. Freeman, L. Rohrer, J. Zabrecky, P. Matsudaira, and M. Krieger. 1990. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature. 343: 531-535.
7. Rohrer, L., M. Freeman, T. Kodama, M. Penman, and M. Krieger. 1990. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature. 343: 570-572.
8. Freeman, M., Y. Ekkel, L. Rohrer, M. Penman, N. J. Freedman, G. M. Chisolm, and M. Krieger. 1991. Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and non-reciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 88: 4931-4935.
9. Palinski, W., M. E. Rosenfeld, S. Ylä-Herttuala, G. C. Gurtner, S. S. Socher, S. W. Butler, S. Parthasarathy, T. E. Carew, D. Steinberg, and J. L. Witztum. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86: 1372-1376.
10. Ylä-Herttuala, S., W. Palinski, M. E. Rosenfeld, S. Parthasarathy, T. E. Carew, S. Butler, J. L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
11. Holvoet, P., and D. Collen. 1994. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 8: 1279-1284.
12. Hessler, J. R., A. L. Robertson, Jr., and G. M. Chisolm. 1979. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis. 32: 213-229.
13. Berliner, J. A., M. C. Territo, A. Sevanian, S. Ramin, J. A. Kim, B. Bamshad, M. Esterson, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85: 1260-1266.
14. 1 macrophages exposed to oxidized low-density lipoprotein. FEBS Lett. 332: 218-220.
15. Reid, V. C., and M. J. Mitchinson. 1993. Toxicity of oxidized low density lipoprotein towards mouse peritoneal macrophages in vitro. Atherosclerosis. 98: 17-24.
16. Aqel, N. M., R. Y. Ball, H. Waldmann, and M. J. Mitchinson. 1985. Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies. J. Pathol. 146: 197-204.
17. Marchant, C. E., N. S. Law, C. van der Veen, S. J. Hardwick, K. L. H. Carpenter, and M. J. Mitchinson. 1995. Oxidized low-density lipoprotein is cytotoxic to human monocyte-macrophages: protection with lipophilic antioxidants. FEBS Lett. 358: 175-178.
18. Murakami, M., S. Horiuchi, K. Takata, and Y. Morino. 1987. Distinction in the mode of receptor-mediated endocytosis between high density lipoprotein and acetylated high density lipoprotein: evidence for high density lipoprotein receptor-mediated cholesterol transfer. J. Biochem. (Tokyo) 101: 729-741.
19. 2+-catalyzed oxidation of human low density lipoprotein. FEBS Lett. 257: 435-438.
20. Sakai, M., A. Miyazaki, H. Hakamata, T. Sasaki, S. Yui, M. Yamazaki, M. Shichiri, and S. Horiuchi. 1994. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on marine macrophages. J. Biol. Chem. 269: 31430-31435.
21. McFarlane, A. S. 1958. Efficient trace-labelling of proteins with iodine. Nature. 182: 53.
22. Miyazaki, A., M. Sakai, Y. Suginohara, H. Hakamata, Y. Sakamoto, W. Morikawa, and S. Horiuchi. 1994. Acetylated low density lipoprotein reduces its ligand activity for the scavenger receptor after interaction with reconstituted high density lipoprotein. J. Biol. Chem. 269: 5264-5269.
23. Hara-Kuge, S., F. Amano, M. Nishijima, and Y. Akamatsu. 1990. Isolation of a lipopolysaccharide (LPS)-resistant mutant, with defective LPS binding, of cultured macrophage-like cells. J. Biol. Chem. 265: 6606-6610.
24. Suginohara, Y., A. Miyazaki, H. Hakamata, Y. Sakamoto, T. Ohta, I. Matsuda, and S. Horiuchi. 1996. The heparin-bound fraction of human lipoprotein-deficient serum inhibits endocytic uptake of oxidized low density lipoprotein by macrophages. Atherosclerosis. 120: 167-179.
25. Hakamata, H., A. Miyazaki, M. Sakai, Y. Sakamoto, H. Matsuda, K. Kihara, and S. Horiuchi. 1995. Differential effects of an acyl-coenzyme A:cholesterol acyltransferase inhibitor on HDL-induced cholesterol efflux from rat macrophage foam cells. FEBS Lett. 363: 29-32.
26. Heider, J. G., and R. L. Boyett. 1978. The picomole determination of free and total cholesterol in cells in culture. J. Lipid Res. 19: 514-518.
27. Hoppe, G., J. O'Neil, and H. F. Hoff. 1994. Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages. J. Clin. Invest. 94: 1506-1512.
28. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Second Edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
29. Matsuda, H., H. Hakamata, A. Miyazaki, M. Sakai, C. C. Y. Chang, T-Y. Chang, S. Kobori, M. Shichiri, and S. Horiuchi. 1996. Activation of acyl-coenzyme A:cholesterol acyltransferase activity by cholesterol is not due to altered mRNA levels in HepG2 cells. Biochim. Biophys. Acta. 1301: 76-84.
30. Ashkenas, J., M. Penman, E. Vasile, S. Acton, M. Freeman, and M. Krieger. 1993. Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors. J. Lipid Res. 34: 983-1000.
31. Tso, J. Y., X-H. Sun, T. Kao, K. S. Reece, and R. Wu. 1985. Isolation and characterization of rat and human glycer-aldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13: 2485-2502.
32. Suzuki, H., Y. Kurihara, M. Takeya, N. Kamada, M. Kataoka, K. Jishage, O. Ueda, H. Sakaguchi, T. Higashi, T. Suzuki, Y. Takashima, Y. Kawabe, O. Cynshi, Y. Wada, M. Honda, H. Kurihara, H. Aburatani, T. Doi, A. Matsumoto, S. Azuma, T. Noda, Y. Toyoda, H. Itakura, Y. Yazaki, S. Horiuchi, K. Takahashi, J. K. Kruijt, T. J. C van Berkel, U. P. Steinbrecher, S. Ishibashi, N. Maeda, S. Gordon, and T. Kodama. 1997. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 386: 292-296.
33. Guyton, J. R., B. L. Black, and C. L. Seidel. 1990. Focal toxicity of oxysterols in vascular smooth muscle cell culture: a model of the atherosclerotic core region. Am. J. Pathol. 137: 425-434.
34. Chisolm, G. M., G. Ma, K. C. Irwin, L. L. Martin, K. G. Gunderson, L. F. Linberg, D. W. Morel, and P. E. DiCorleto. 1994. 7β-Hydroperoxycholest-5-en-3β-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc. Natl. Acad. Sci. USA. 91: 11452-11456.
35. Colles, S. M., K. C. Irwin, and G. M. Chisolm. 1996. Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7β-hydroperoxycholesterol. J. Lipid Res. 37: 2018-2028.
36. Hughes, H., B. Mathews, M. L. Lenz, and J. R. Guyton. 1994. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arterioscler. Thromb. 14: 1177-1185.
37. Thomas, J. P., P. G. Geiger, and A. W. Girotti. 1993. Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxide in cytoprotection against lipid hydroperoxide- and iron-induced reactions. J. Lipid Res. 34: 479-490.
38. Kuzuya, M., M. Naito, C. Funai, T. Hayashi, K. Asai, and F. Kuzuya. 1991. Lipid peroxide and transition metals are required for the toxicity of oxidized low density lipoprotein to cultured endothelial cells. Biochim. Biophys. Acta. 1096: 155-166.
39. Naito, M., K. Yamada, T. Hayashi, K. Asai, N. Yoshimine, and A. Iguchi. 1994. Comparative toxicity of oxidatively modified low-density lipoprotein and lysophosphatidylcholine in cultured vascular endothelial cells. Heart Vessels. 9: 183-187.
40. 2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis. 112: 69-76.
41. Freeman, M., J. Ashkenas, D. J. G. Rees, D. M. Kingsley, N. G. Copeland, N. A. Jenkins, and M. Krieger. 1990. An ancient, highly conserved family of cysteine rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc. Natl. Acad. Sci. USA. 87:8810-8814.
42. Chisolm, G. M. 1991. Cytotoxicity of oxidized lipoproteins. Curr. Opin. Lipidol. 2: 311-316.
43. Hessler, J. R., D. W. Morel, L. J. Lewis, and G. M. Chisolm. 1983. Lipoprotein oxidation and lipoprotein-induced cytotoxity. Arteriosclerosis. 3: 215-222.
44. Schmitt, A., A. Nègre-Salvayre, M. Troly, P. Valdiguié, and R. Salvayre. 1995. Phospholipid hydrolysis of mildly oxidized LDL reduces their cytotoxicity to cultured endothelial cells. Potential protective role against atherogenesis. Biochim. Biophys. Acta. 1256: 284-292.
45. Nègre-Salvayre, A., M. Lopez, T. Levade, M-T. Pieraggi, N. Dousset. L. Douste-Blazy, and R. Salvayre. 1990. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. II. Uptake and cytotoxicity of ultraviolet-treated LDL on lymphoid cell lines. Biochim. Biophys. Acta. 1045: 224-232.
46. Brown, M. S., and J. L. Goldstein. 1983. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52: 223-261.
47. Stanton, L. W., R. Tyler White, C. M. Bryant, A. A. Protter, and G. Endemann. 1992. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J. Biol. Chem. 267: 22446-22451.
48. Ramprasad, M. P., W. Fischer, J. L. Witztum, G. R. Sambrano, O. Quehenberger, and D. Steinberg. 1995. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc. Natl. Acad. Sci. USA. 92: 9580-9584.
49. Endemann, G., L. W. Stanton, K. S. Madden, C. M. Bryant, R. Tyler White, and A. A. Protter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268: 11811-11816.
50. Sawamura, T., N. Kume, T. Aoyama, H. Moriwaki, H. Hoshikawa, Y. Aiba, T. Tanaka, S. Miwa, Y. Katsura, T. Kita, and T. Masaski. 1997. An endothelial receptor for oxidized low-density lipoprotein. Nature. 386: 73-77.
51. Nozaki, S., H. Kashiwagi, S. Yamashita, T. Nakagawa, B. Kostner, Y. Tomiyama, A. Nakata, M. Ishigami, J. Miyagawa, K. Kameda-Takemura, Y. Kurata, and Y. Matsuzawa. 1995. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J. Clin. Invest. 96: 1859-1865.
52. Sakai, M., A. Miyazaki, H. Hakamata, T. Kodama, H. Suzuki, S. Kobori, M. Shichiri, and S. Horiuchi. 1996. The scavenger receptor serves as a route for internalization of lysophosphatidylcholine in oxidized low density lipoprotein-induced macrophage proliferation. J. Biol. Chem. 271: 27346-27352.
53. Kerr, J. F. R., A. H. Wyllie, and A. R. Currie. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26: 239-257.
54. Vaux, D. L., H. Georg, and A. Strasser. 1994. An evolutionary perspective on apoptosis. Cell. 76: 777-779.
55. Cohen, G. M., X-M. Sun, R. T. Snowden, D. Dinsdale, and D. N. Skilleter. 1992. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 286: 331-334.
56. Oberhammer, F., G. Fritsch, M. Schmied, M. Pavelka, D. Printz, T. Purchio, H. Lassmann, and R. Schulte-Hermann. 1993. Condensation of chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J. Cell Sci. 104: 317-326.
57. Tomei, L. D., J. P. Shapiro, and F. O. Cope. 1993. Apoptosis in C3H/10T1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc. Natl. Acad. Sci. USA. 90: 853-857.
58. Yui, S., T. Sasaki, A. Miyazaki, S. Horiuchi, and M. Yamazaki. 1993. Induction of marine macrophage growth by modified LDLs. Arterioscler. Thromb. 13: 331-337.
59. Sakai, M., A. Miyazaki, H. Hakamata, Y. Sato, T. Matsumura, S. Kobori, M. Shichiri, and S. Horiuchi. 1996. Lysophosphatidylcholine potentiates the mitogenic activity of modified low density lipoproteins for human monocyte-derived macrophages. Arterioscler: Thromb. Vasc. Biol. 16: 600-605.
60. Sato, Y., S. Kobori, M. Sakai, T. Yano, T. Higashi, T. Matsumura, W. Morikawa, T. Terano, A. Miyazaki, S. Horiuchi, and M. Shichiri. 1996. Lipoprotein[a] induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-β activation. Atherosclerosis. 125: 15-26.